Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

DECLARE HF

89 views

Published on

En ACC Scientific Sessions se presentan los resultados del subanálisis del DECLARE en relación al efecto de dapagliflozina en insuficiencia cardiaca. El Dr. Alberto Esteban comenta el ensayo en #SECenACC19.

Published in: Science
  • Be the first to comment

  • Be the first to like this

DECLARE HF

  1. 1. DECLARE (HF) DECLARE: Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus Based on Ejection Fraction Results form the DECLARE-TIMI 58 Trial Alberto Esteban Fern�ndez
  2. 2. DECLARE (HF) Alberto Esteban Fern�ndez
  3. 3. DECLARE (HF) Alberto Esteban Fern�ndez
  4. 4. DECLARE (HF) Alberto Esteban Fern�ndez
  5. 5. DECLARE (HF) Alberto Esteban Fern�ndez
  6. 6. DECLARE (HF) Alberto Esteban Fern�ndez
  7. 7. DECLARE (HF) Alberto Esteban Fern�ndez
  8. 8. DECLARE (HF) Alberto Esteban Fern�ndez
  9. 9. DECLARE (HF) Alberto Esteban Fern�ndez
  10. 10. DECLARE (HF) Alberto Esteban Fern�ndez
  11. 11. DECLARE (HF) Alberto Esteban Fern�ndez

×